Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 07, 2024

SELL
$240.69 - $338.77 $42.3 Million - $59.6 Million
-175,850 Reduced 94.88%
9,486 $2.3 Million
Q3 2023

Nov 13, 2023

SELL
$240.69 - $338.77 $42.3 Million - $59.6 Million
-175,850 Reduced 94.88%
9,486 $2.3 Million
Q2 2023

Oct 07, 2024

BUY
$271.54 - $344.06 $10.8 Million - $13.7 Million
39,818 Added 27.36%
185,336 $63.8 Million
Q2 2023

Aug 14, 2023

BUY
$271.54 - $344.06 $10.8 Million - $13.7 Million
39,818 Added 27.36%
185,336 $63.8 Million
Q1 2023

Oct 07, 2024

BUY
$220.43 - $278.69 $26.9 Million - $34 Million
122,018 Added 519.23%
145,518 $40.6 Million
Q1 2023

May 12, 2023

BUY
$220.43 - $278.69 $26.9 Million - $34 Million
122,018 Added 519.23%
145,518 $40.6 Million
Q4 2022

Oct 07, 2024

BUY
$151.88 - $228.5 $3.57 Million - $5.37 Million
23,500 New
23,500 $5.23 Million
Q4 2022

Feb 10, 2023

SELL
$151.88 - $228.5 $24.5 Million - $36.9 Million
-161,500 Reduced 87.3%
23,500 $5.23 Million
Q3 2022

Nov 14, 2022

BUY
$120.36 - $205.88 $22.3 Million - $38.1 Million
185,000 New
185,000 $35.1 Million
Q4 2020

Feb 09, 2021

SELL
$174.98 - $272.83 $33.4 Million - $52 Million
-190,762 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$185.27 - $238.73 $1.5 Million - $1.93 Million
8,099 Added 4.43%
190,762 $37.1 Million
Q2 2020

Aug 14, 2020

BUY
$153.32 - $191.72 $2.59 Million - $3.24 Million
16,915 Added 10.21%
182,663 $32.7 Million
Q1 2020

May 14, 2020

SELL
$124.34 - $193.76 $1.57 Million - $2.44 Million
-12,616 Reduced 7.07%
165,748 $26.7 Million
Q4 2019

Feb 14, 2020

SELL
$134.81 - $177.8 $31.6 Million - $41.7 Million
-234,732 Reduced 56.82%
178,364 $29.3 Million
Q3 2019

Nov 14, 2019

SELL
$131.82 - $183.4 $22.8 Million - $31.7 Million
-172,842 Reduced 29.5%
413,096 $55.6 Million
Q2 2019

Aug 14, 2019

BUY
$124.65 - $167.39 $491,993 - $660,688
3,947 Added 0.68%
585,938 $93.8 Million
Q1 2019

May 15, 2019

SELL
$115.84 - $160.31 $8.76 Million - $12.1 Million
-75,648 Reduced 11.5%
581,991 $85.6 Million
Q4 2018

Feb 14, 2019

BUY
$113.42 - $156.48 $16.7 Million - $23 Million
146,889 Added 28.76%
657,639 $80.4 Million
Q3 2018

Nov 14, 2018

SELL
$121.55 - $156.8 $36.7 Million - $47.3 Million
-301,628 Reduced 37.13%
510,750 $76.5 Million
Q2 2018

Aug 14, 2018

BUY
$112.2 - $165.95 $28.8 Million - $42.5 Million
256,348 Added 46.1%
812,378 $112 Million
Q1 2018

May 15, 2018

SELL
$84.6 - $126.1 $6.17 Million - $9.19 Million
-72,902 Reduced 11.59%
556,030 $64.3 Million
Q4 2017

Feb 14, 2018

SELL
$91.55 - $115.85 $2.16 Million - $2.73 Million
-23,559 Reduced 3.61%
628,932 $59.2 Million
Q3 2017

Nov 14, 2017

SELL
$79.65 - $90.3 $35.1 Million - $39.8 Million
-441,130 Reduced 40.34%
652,491 $58.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,093,621
1,093,621 $96 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.28B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.